The global in vitro fertilization (IVF) market is projected to grow from USD 949 million in 2024 to USD 1,650 million by 2029, at a CAGR of 11.7% during the forecast period. Market growth is primarily driven by the increasing prevalence of infertility worldwide, largely associated with delayed parenthood, lifestyle changes, and underlying medical conditions affecting reproductive health.
Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=89198891
The growing acceptance of assisted reproductive technologies (ART), along with advancements in IVF procedures and laboratory equipment, is further accelerating market expansion. Increasing awareness, improving success rates, and expanding access to fertility clinics are encouraging more individuals and couples to opt for IVF treatments.
IVF Equipment Segment to Register Significant Growth
By product, the IVF equipment segment is expected to witness significant growth during the forecast period. Equipment such as imaging systems, incubators, microscopes, micromanipulators, and gas analyzers play a critical role in ensuring the success and efficiency of IVF procedures.
Advanced microscopes enable precise evaluation of sperm quality, egg maturity, and embryo development, supporting clinical decision-making at every stage. Incubators provide optimal environmental conditions for embryo growth, while centrifuges are essential for sperm preparation in procedures such as intracytoplasmic sperm injection (ICSI). Specialized tools like embryo transfer catheters further enhance implantation success rates, contributing to improved treatment outcomes.
Fresh Non-Donor IVF Cycles Dominate Market
By cycle type, fresh non-donor IVF accounted for the largest share of the market in 2023. This approach remains highly preferred as it allows individuals or couples to use their own genetic material, aligning with personal, cultural, and familial preferences.
Fresh IVF cycles are often associated with higher success rates compared to frozen or donor-based procedures, while also being more cost-effective. The ability to proceed with treatment without delays related to donor selection or embryo thawing further enhances its appeal. Additionally, personalized treatment protocols tailored to individual fertility conditions contribute to its widespread adoption.
Speak To Analyst:- https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=89198891
Asia Pacific Emerges as a High-Growth Region
The Asia Pacific region represents a significant and rapidly growing market for IVF services. Factors such as rising infertility rates, large population base, and improving healthcare infrastructure are driving growth across countries like China, India, and Southeast Asia.
Increasing disposable incomes and growing awareness of fertility treatments are enabling more patients to access IVF services. Government support for healthcare development and the expansion of modern fertility clinics are further strengthening the region’s position as a major hub for assisted reproductive technologies.
North America held the largest share of the market in 2023, supported by advanced healthcare systems, high adoption of fertility treatments, and the presence of leading IVF service providers.
Competitive Landscape
Key players in the IVF market include CooperSurgical Inc. (US), Cook Group (US), Vitrolife (Sweden), Hamilton Thorne Ltd. (US), and FUJIFILM Irvine Scientific (Japan), among others.
These companies are focusing on technological innovation, product development, and strategic collaborations to enhance treatment success rates and expand their global presence in the fertility care market.
